Researchers plan to test the effectiveness of transfusing blood products from Ebola survivors into infected patients, as a potential near-term countermeasure to the outbreak in West Africa.
via WSJ.com: World News http://ift.tt/1oyINNJ
via WSJ.com: World News http://ift.tt/1oyINNJ
Nessun commento:
Posta un commento